Abstract

PurposeThe aim of this study was to compare diffusion tensor imaging (DTI) isotropic map (p-map) with current radiographically (T2/T2-FLAIR) methods based on abnormal hyper-signal size and location of glioblastoma tumor using a semi-automatic approach.Materials and methodsTwenty-five patients with biopsy-proved diagnosis of glioblastoma participated in this study. T2, T2-FLAIR images and diffusion tensor imaging (DTI) were acquired 1 week before radiotherapy. Hyper-signal regions on T2, T2-FLAIR and DTI p-map were segmented by means of semi-automated segmentation. Manual segmentation was used as ground truth. Dice Scores (DS) were calculated for validation of semiautomatic method. Discordance Index (DI) and area difference percentage between the three above regions from the three modalities were calculated for each patient.ResultsArea of abnormality in the p-map was smaller than the corresponding areas in the T2 and T2-FLAIR images in 17 patients; with mean difference percentage of 30 ± 0.15 and 35 ± 0.15, respectively. Abnormal region in the p-map was larger than the corresponding areas in the T2-FLAIR and T2 images in 4 patients; with mean difference percentage of 26 ± 0.17 and 29 ± 0.28, respectively. This region in the p-map was larger than the one in the T2 image and smaller than the one in the T2-FLAIR image in 3 patients; with mean difference percentage of 34 ± 0.08 and 27 ± 0.06, respectively. Lack of concordance was observed ranged from 0.214–0.772 for T2-FLAIR/p-map (average: 0.462 ± 0.18), 0.266–0.794 for T2 /p-map (average: 0.468 ± 0.13) and 0.123–0.776 for T2/ T2-FLAIR (average: 0.423 ± 0.2). These regions on three modalities were segmented using a semi-automatic segmentation method with over 86% sensitivity, 90% specificity and 89% dice score for three modalities.ConclusionIt is noted that T2, T2-FLAIR and DTI p-maps represent different but complementary information for delineation of glioblastoma tumor margins. Therefore, this study suggests DTI p-map modality as a candidate to improve target volume delineation based on conventional modalities, which needs further investigations with follow-up data to be confirmed.

Highlights

  • Glioblastoma is the most aggressive brain tumor in adults

  • Abnormal region in the p-map was larger than the corresponding areas in the T2-Fluid Attenuation Inversion Recovery (FLAIR) and T2 images in 4 patients; with mean difference percentage of 26 ± 0.17 and 29 ± 0.28, respectively

  • It is noted that T2, T2-FLAIR and diffusion tensor imaging (DTI) p-maps represent different but complementary information for delineation of glioblastoma tumor margins

Read more

Summary

Introduction

Glioblastoma is the most aggressive brain tumor in adults. The current standard of care for patients with glioblastoma is maximal safe surgical de-bulking, followed by adjuvant radiotherapy with concurrent and adjuvant Temozolomide chemotherapy [1].Diffuse and infiltrative growth of this tumor is a major determinant of poor prognosis. Glioblastoma is the most aggressive brain tumor in adults. The current standard of care for patients with glioblastoma is maximal safe surgical de-bulking, followed by adjuvant radiotherapy with concurrent and adjuvant Temozolomide chemotherapy [1]. Unclear boundary and escaped invasive tumor cells are prominent aspects of glioblastoma, making accurate delineation of tumor boundary impossible using conventional MRI (cMRI). Tumor delineation using cMRI is a necessary prerequisite step in diagnostic and therapeutic (monitoring treatment response) radiology in glioblastoma. Treatment planning for glioblastoma tends to include the contrast-enhancing tumor on CT/T1-weighted MRI plus a 2 cm margin, or the T2-FLAIR/T2-weighted abnormality on the postoperative MRI scan plus a 1 cm margin [1]. Identifying the extension of abnormal region has been improved with recent evolutionary developments in MRI techniques [2]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call